Pfizer Stock Calculator
Estimate your Pfizer ($PFE) stock returns over time
Pfizer Investment Calculator
Calculate potential returns on your Pfizer stock investment using historical performance data.
Investment Projection Results
Initial Investment:
—
Hold Period:
—
Expected Annual Return:
—
Future Value:
—
Total Return:
—
What This Means For You
Enter your investment details above to see personalized insights.
Investment Growth Over Time
Frequently Asked Questions
This calculator allows you to project returns on Pfizer stock over time. Input your initial investment, holding period, and return rate. Experiment with different values to see how compounding impacts your potential growth.
Pfizer has demonstrated varying returns across different time periods. The 5Y return of -14.04% provides the most comprehensive historical view. Our weighted average annual return of -26.22% gives more weight to longer-term performance. However, past performance doesn't guarantee future results, and returns can vary significantly year to year.
Several factors can influence Pfizer's stock performance:
- Company earnings and revenue growth
- Market conditions and economic trends
- Industry-specific developments
- Company announcements and news
- Overall market sentiment
The calculator provides two key metrics:
Future Value
The projected value of your investment at the end of your holding period
Total Return
The absolute dollar amount gained or lost, plus the percentage return on your investment
Remember that these are projections based on your inputs and historical data. Actual returns may differ significantly.
Explore More Stock Calculators
Historical Returns
1Y Return
-13.08%
2Y Return
-30.82%
3Y Return
-49.41%
4Y Return
-27.19%
5Y Return
-14.04%
YTD Return
-9.10%
Last Updated: 2025-06-04 14:21:11
Pfizer Information
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Business Classification
Sector
Healthcare
Industry
Drug Manufacturers - General
Location
New York, NY, United States
Company Size
81,000 employees
Website
Resources & Data Sources
Stock data powered by
Yahoo Finance API
Company logos provided by
Parqet Logo API
Market data and calculations are for informational purposes only and should not be considered as financial advice.
